Agarwal, NehaGandhi, GauriBatra, SwarajSharma, Rachna2017-02-032017-02-032014-02Agarwal Neha, Gandhi Gauri, Batra Swaraj, Sharma Rachna. Evaluation of Mifepristone and Misoprostol for Medical Termination of Pregnancy Between 13-20 Weeks of Gestation. Indian Journal of Clinical Practice. 2014 Feb; 24(9): 859-862.http://imsear.searo.who.int/handle/123456789/182970Aim: To assess the efficacy, safety and acceptability of mifepristone followed by vaginal misoprostol for medical termination of pregnancy (MTP) between 13-20 weeks of gestation. Material and methods: Forty women who fulfilled the criteria of MTP Act of India, were given 200 mg oral mifepristone, followed after 36-48 hours by 800 μg vaginal misoprostol and subsequently 400 μg vaginal misoprostol 3-hourly (maximum 2,400 μg). Success was taken as complete expulsion of fetus and placenta within 15 hours of first dose of misoprostol. Results: Success rate of complete abortion was 92.5%, which increased to 95% at 24 hours and successful expulsion of fetus was seen in 100% cases within 24 hours of first dose of misoprostol. Median induction-abortion interval was 6 hours. There were no major side effects. Nulliparous women took significantly longer time to abortion and required more analgesia than multiparous women. Conclusion: Mifepristone followed by vaginal misoprostol is a safe, effective and acceptable method for second trimester termination of pregnancy.enMifepristonemisoprostolsecond trimester termination of pregnancyArticle